Cubist Pharmaceuticals, Inc. (CBST) Tops Q3 EPS by 10c

October 18, 2012 4:00 PM EDT
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q3 EPS of $0.55, $0.10 better than the analyst estimate of $0.45. Revenue for the quarter came in at $238.2 million versus the consensus estimate of $240.04 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings